Krystal Biotech, Inc. (KRYS) Net income 2016–2025
Krystal Biotech, Inc. (KRYS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$204.8MFY2025 · since FY2016: -$1.1M → $204.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $204.8M | +129.7% |
| FY2024 | $89.2M | +715.6% |
| FY2023 | $10.9M | +107.8% |
| FY2022 | -$140.0M | -101.2% |
| FY2021 | -$69.6M | -116.3% |
| FY2020 | -$32.2M | -68.5% |
| FY2019 | -$19.1M | -75.3% |
| FY2018 | -$10.9M | -37.5% |
| FY2017 | -$7.9M | -588.7% |
| FY2016 | -$1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice